These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20890581)

  • 41. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
    Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
    Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Early detection of prostate cancer: is serum PSA testing alone sufficient?].
    Börgermann C; Vom Dorp F; Breuer G; Kliner S; Rübben H
    Urologe A; 2010 Nov; 49(11):1351-5. PubMed ID: 20959954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beyond PSA: the next generation of prostate cancer biomarkers.
    Prensner JR; Rubin MA; Wei JT; Chinnaiyan AM
    Sci Transl Med; 2012 Mar; 4(127):127rv3. PubMed ID: 22461644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X; Foj L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.
    Knipe DW; Evans DM; Kemp JP; Eeles R; Easton DF; Kote-Jarai Z; Al Olama AA; Benlloch S; Donovan JL; Hamdy FC; Neal DE; Smith GD; Lathrop M; Martin RM
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1356-1365. PubMed ID: 24753544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From pro-prostate specific antigen, [-2]pro-prostate specific antigen to Beckman Coulter phi: the evolution of new biomarkers for early detection of prostatic carcinoma.
    Zhang MZ; Lu YP
    Chin Med J (Engl); 2012 May; 125(9):1643-9. PubMed ID: 22800836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Usefulness of prostate specific antigen/gamma-seminoprotein ratio for diagnosis of prostate cancer].
    Demura T; Watarai Y; Togashi M; Oohashi N; Chikaraishi T; Hirano T
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1046-53. PubMed ID: 7688442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients.
    Brait M; Banerjee M; Maldonado L; Ooki A; Loyo M; Guida E; Izumchenko E; Mangold L; Humphreys E; Rosenbaum E; Partin A; Sidransky D; Hoque MO
    Oncotarget; 2017 Feb; 8(9):15431-15440. PubMed ID: 28147335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States).
    Sieh W; Edwards KL; Fitzpatrick AL; Srinouanprachanh SL; Farin FM; Monks SA; Kronmal RA; Eaton DL
    Cancer Causes Control; 2006 Mar; 17(2):187-97. PubMed ID: 16425097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate-specific antigen: biochemistry, analytical methods, and clinical application.
    Armbruster DA
    Clin Chem; 1993 Feb; 39(2):181-95. PubMed ID: 7679336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination.
    Finne P; Auvinen A; Aro J; Juusela H; Määttänen L; Rannikko S; Hakama M; Tammela TL; Stenman UH
    Eur Urol; 2002 Jun; 41(6):619-26; discussion 626-7. PubMed ID: 12074779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia.
    Huang J; Reilly KH; Zhang HZ; Wang HB
    BMC Urol; 2015 Dec; 15():118. PubMed ID: 26628213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer].
    Kovács GL
    Magy Onkol; 2014 Dec; 58(4):301-9. PubMed ID: 25517448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urine biomarkers in prostate cancer.
    Ploussard G; de la Taille A
    Nat Rev Urol; 2010 Feb; 7(2):101-9. PubMed ID: 20065953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer.
    Cornu JN; Cancel-Tassin G; Egrot C; Gaffory C; Haab F; Cussenot O
    Prostate; 2013 Feb; 73(3):242-9. PubMed ID: 22821767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Non- PSA serum markers for the diagnosis of PCa].
    Mengual L; Musquera M; Ciudin A; Ribal MJ
    Arch Esp Urol; 2015 Apr; 68(3):229-39. PubMed ID: 25948796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic predisposition to prostate cancer.
    Benafif S; Eeles R
    Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer.
    Cao L; Lee CH; Ning J; Handy BC; Wagar EA; Meng QH
    Arch Pathol Lab Med; 2018 Sep; 142(9):1106-1112. PubMed ID: 29547000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycosylated biomarker sensors: advancements in prostate cancer diagnosis.
    Abd Rahman SF; Md Arshad MK; Gopinath SCB; Fathil MFM; Sarry F; Ibau C
    Chem Commun (Camb); 2021 Sep; 57(76):9640-9655. PubMed ID: 34473143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Biomarkers for Prostate Cancer Detection and Prognosis.
    Filella X; Foj L
    Adv Exp Med Biol; 2018; 1095():15-39. PubMed ID: 30229547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.